Addressing Disparities and Variations in Care in GU OncologyCME Available: auau.auanet.org/node/37337Host: Jay D. Raman, MD, FACSGuests: Kelvin Moses, MD, PhD and Svetlana Avulova, MDLEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Discuss the impact of race and cultural barriers on optimal GU cancer care.2. Evaluate financial toxicity as a barrier to optimal patient care in urologic cancer.3. Incorporate culturally sensitive communications to ensure quality care and reduce biases across diverse patient populations.ACKNOWLEDGEMENTS:This series is supported by independent educational grants from:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerck & Co., Inc.Pfizer, Inc.Sanofi Genzyme